TAMPA, Fla., July 16, 2012 /PRNewswire-iReach/ -- Mr. James Gibson, President & CEO of Integrity Life Sciences announced today that Integrity Life Sciences is the owner of 2 (two) US Patents:
(Photo: http://photos.prnewswire.com/prnh/20120716/CG40319)
- Apparatus for Therapeutic Treatment of Low Back Pain
(US Patent #6,152,950)
- Integrated Lumbar Combined Variable Angular Distraction Structure
(US Patent #7,462,189)
Abstracts of both patents are contained in this press release. For a full and complete copy of these patents, please submit your request in writing to Integrity Life Sciences.
According the US Patent and Trademark Office, a patent is an intellectual property right granted by the Government of the United States of America to an inventor, or owner of patent, the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States. Integrity fully intends to work with any US governmental authority to assist in full compliance with the protection of its intellectual property rights.
Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain. The advanced solution begins with the Integrity Spinal Care System (ISCS 2.0) and The Lombare System. Both medical devices are non-surgical spinal decompression therapy systems engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.
While Integrity Life Sciences is not the first company that applied for non surgical decompression, our founder James J. Gibson, Jr. was the first to apply based upon previously marketed machines that are noted as substantially equivalent predicate devices which are the DRS System and the DRX9000, also marketed as a DRX 9000 combo or the DRX9000C. Additionally, the DRS System was the first non surgical spinal decompression device to receive a US Patent where the patient was treated in the supine position with an angular distraction force. The DRS System was manufactured and distributed by Cluster Technology Corp, and its wholly owned subsidiaries. Mr. Gibson had a multiyear career at Cluster Technology that included tenure as an Officer, President, and CEO and also served on Cluster’s Board of Directors with other distinguished industry professionals. It was during Mr. Gibson’s tenure at Cluster that the DRS System‘s US FDA 510(k), patent and trademark submissions and international market expansion were secured.
Mr. James Gibson is also the original founder and President & CEO of Axiom Worldwide, Inc., the originator of all DRX 9000 devices. While at Axiom Worldwide, Mr. Gibson was responsible for all of Axiom Worldwide’s US FDA 510(k)s, patent and trademark applications. The DRX9000, also marketed as a DRX 9000 combo or the DRX9000C, was also recognized internationally by various hybrid names to include the DRX 2000, DRX 3000, and DRX 5000. Under Mr. Gibson’s tutelage, Axiom Worldwide obtained multiple US FDA 510(k)s, patent applications were submitted and trademarks achieved. Additionally, Axiom Worldwide products were sold and represented on nearly every continent around the world.
PATENT ABSTRACTS
Abstract: Apparatus for Therapeutic Treatment of Low Back Pain
US Patent #6,152,950
A therapeutic traction table for the treatment of low back pain includes a bed pivotable from a vertical to a horizontal position for facilitating the placement of a person in a horizontal position on the bed. An upper body harness and underarm supports anchor the upper body of the person to the bed. A lower body harness is attached to the lower body pelvic portion of the person, and includes an inflatable air bladder for positioning within the posterior cavity of the lumbar spine formed between the lower back of the person and the bed for relaxing low back muscles during a pulling force on the spine. A traction unit includes a strap connected to the lower body harness for providing a pulling force between the upper body and the lower body. The traction unit is vertically movable from a position generally along an axis of the spine to a vertically displaced position for pulling at a pre-selected and measurable angle to the axis of the spine and isolating the pulling force to a preselected portion of the spine during a programmable back treatment protocol.
Abstract: Integrated Lumbar Combined Variable Angular Distraction Structure
US Patent #7,462,189
A spinal treatment apparatus for applying a force to a patient includes a base portion, a telescoping support, a spinal distraction device and an actuator. The telescoping support is mounted on the base portion and includes a bottom member and a top member. The top member is engaged with the bottom member so that the top member has a retracted position and an extended position. The telescoping support is capable of withstanding a force, corresponding to the spinal treatment force, imparted on the top member, while in both the retracted position and the extended position. The spinal distraction device is mounted on the top member and applies the spinal treatment force to the patient. The actuator moves the top member vertically relative to the bottom member.
Integrity Life Sciences is a privately held USA based company with international partners located across the globe with a mission of “Restoring Integrity to the Spine”. For additional information please visit: www.IntegrityLifeSciences.com. To schedule an interview please contact: James Gibson, President & CEO via telephone: +1-813-935-5500 or email: James@IntegrityLifeSciences.com.
Media Contact:James Gibson, Integrity Life Sciences, LLC, 813-935-5500, james@integritylifesciences.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Integrity Life Sciences, LLC